3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Neoplasm Metastasis
3
Philadelphia Chromosome
2
Ovarian Neoplasms
2
Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Sarcoma
1
Recurrence
1
Peritoneal Neoplasms
1
Neoplasm, Residual
1
Leukemia, Myeloid
1
Hematologic Diseases
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Blast Crisis
1
Appendiceal Neoplasms
1
Interventions
Cisplatin
11
pembrolizumab
10
Carboplatin
7
Radiotherapy
6
Cetuximab
6
Docetaxel
5
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Cyclophosphamide
3
fludarabine
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
vistusertib
1
toripalimab
1
sitravatinib
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
lenvatinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
nilotinib
×
90 days
×
Clear all
No trials found.